• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Laura C. Collins, M.B.B.S.

Assistant Professor, Department of Pathology, Harvard Medical School

Associate Director, Pathology, Beth Israel Deaconess Medical Center

Contact Info

Laura Collins
Beth Israel Deaconess Medical Center
330 Brookline Avenue
Boston, MA, 02215
Phone not available.
lcollins@bidmc.harvard.edu

Assistant

Not Available.

DF/HCC Program Affiliation

Breast Cancer
Cancer Epidemiology

Research Abstract

Not Available.

Publications

  • Collins LC, Carlo VP, Hwang H, Barry TS, Gown AM, Schnitt SJ.Intracystic Papillary Carcinomas of the Breast: A Reevaluation Using a Panel of Myoepithelial Cell Markers.Am J Surg Pathol 2006 Aug;30(8):1002-1007.
    16861972
  • Upalakalin JN, Collins LC, Tawa N, Parangi S.Carcinoid tumors in the breast.Am J Surg 2006 Jun;191(6):799-805.
    16720153
  • Bryan BB, Schnitt SJ, Collins LC.Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer.Mod Pathol 2006 May;19(5):617-21.
    16528377
  • O'Malley FP, Mohsin SK, Badve S, Bose S, Collins LC, Ennis M, Kleer CG, Pinder SE, Schnitt SJ.Interobserver reproducibility in the diagnosis of flat epithelial atypia of the breast.Mod Pathol 2006 Feb;19(2):172-9.
    16424892
  • Collins LC, Tamimi RM, Baer HJ, Connolly JL, Colditz GA, Schnitt SJ.Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy.Cancer 2005 May 1;103(9):1778-84.
    15770688
  • Collins LC, Botero ML, Schnitt SJ.Bimodal frequency distribution of estrogen receptor immunohistochemical staining results in breast cancer: an analysis of 825 cases.Am J Clin Pathol 2005 Jan;123(1):16-20.
    15762275
  • Collins LC, Schnitt SJ.HER2 protein overexpression in estrogen receptor-positive ductal carcinoma in situ of the breast: frequency and implications for tamoxifen therapy.Mod Pathol 2005 Jan 14.
    15696127